| Product NDC: | 16729-267 |
| Proprietary Name: | Docetaxel |
| Non Proprietary Name: | Docetaxel |
| Active Ingredient(s): | 20 mg/mL & nbsp; Docetaxel |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 16729-267 |
| Labeler Name: | Accord Healthcare Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA201195 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130515 |
| Package NDC: | 16729-267-63 |
| Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (16729-267-63) > 1 mL in 1 VIAL, MULTI-DOSE |
| NDC Code | 16729-267-63 |
| Proprietary Name | Docetaxel |
| Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (16729-267-63) > 1 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 16729-267 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Docetaxel |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20130515 |
| Marketing Category Name | NDA |
| Labeler Name | Accord Healthcare Inc. |
| Substance Name | DOCETAXEL |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |